You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Local Solid Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, NSCLC Trial in Suwon-si, Daejeon, Seoul (GI-101, Pembrolizumab, Lenvatinib)

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • Suwon-si, Kyeonggi-do, Korea, Republic of
  • +3 more
Apr 19, 2022

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Broad Solid Tumor Trial in Worldwide (BMS-986207, Nivolumab, Ipilimumab)

Recruiting
  • Broad Solid Tumor
  • Hackensack, New Jersey
  • +19 more
Jul 26, 2022

Oligometastatic Malignant Solid Tumor Trial in United States (Best Practice, Local Consolidation Therapy)

Recruiting
  • Oligometastatic Malignant Solid Neoplasm
  • Best Practice
  • Local Consolidation Therapy
  • Tuscaloosa, Alabama
  • +12 more
Jul 12, 2022

Solid Tumor Trial in Shanghai (PD-1 blocking antibody)

Recruiting
  • Solid Tumor
  • PD-1 blocking antibody
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 16, 2021

Pan Tumor Trial in Worldwide (Nivolumab, Ipilimumab)

Active, not recruiting
  • Pan Tumor
  • Nivolumab
  • Ipilimumab
  • Santa Monica, California
  • +59 more
Jul 26, 2022

Malignant Solid Tumor Trial in Worldwide (BMS-986179, Nivolumab, rHuPH20)

Completed
  • Malignant Solid Tumor
  • BMS-986179
  • +2 more
  • Chicago, Illinois
  • +23 more
May 25, 2022

Solid Tumor Trial in Beijing (AB-106)

Recruiting
  • Solid Tumor
  • Beijing, China
    Chinese PLA General Hospital
Jun 18, 2021

Solid Tumor Trial in Chuo-ku (ONO-7913)

Active, not recruiting
  • Solid Tumor
  • ONO-7913
  • Chuo-ku, Tokyo, Japan
    Local Institution
May 5, 2021

Eastern Ablation Registry for Solid Tumor (EAST)

Recruiting
  • Solid Tumor Including Thyroid, Bone, Liver, Pancreas
  • RFA, MWA, cryo and IRE
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 11, 2022

Solid Tumors, Adult Trial (tumor treatment vaccine injection)

Not yet recruiting
  • Solid Tumors, Adult
  • tumor treatment vaccine injection
  • (no location specified)
Feb 16, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Tumor Vaccines for Solid Tumors

Recruiting
  • Glioma
  • Solid Tumor
  • tumor vaccine
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 22, 2023

Advanced Solid Tumor Trial (EOC237)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 8, 2023

HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

Not yet recruiting
  • HER2 Positive Advanced Solid Tumors
  • HypoSti.CAR-HER2 T cells
  • +2 more
  • (no location specified)
Jan 12, 2023

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

Recruiting
  • Solid Tumor
  • +4 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 28, 2023

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Solid Tumor, Metastatic Cancer Trial in Belgium (Comprehensive genomic profiling)

Recruiting
  • Solid Tumor
  • Metastatic Cancer
  • Comprehensive genomic profiling
  • Aalst, Belgium
  • +11 more
Sep 16, 2021

Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

Recruiting
  • Tumor, Solid
  • Radiation: 18F-AlF-FAPi-04
  • Radiation: 18F-FDG
  • Nanchong, Sichuan, China
    Affiliated Hospital of North Sichuan Medical College
Nov 6, 2023

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023